Lung Cancer & Oncologic Disorders
- Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access: An Official ATS Statement (2020)
- Initiating Pharmacologic Treatment in Tobacco-Dependent Adults: An Official ATS Clinical Practice Guideline (2020)
- Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis: An Official American Thoracic Society Research Statement (2019)
- Management of Malignant Pleural Effusions: An Official ATS/STS/STR Guideline (2018)
- Incorporating Coexisting Chronic Illness into Lung Cancer Screening: A Research Statement (2018)
- Evaluating biomarkers for the early detection of lung cancer: An Official ATS Policy Statement (2017)
- Research priorities for smoking cessation programs within lung cancer screening programs: An Official ATS Research Statement (2017)
- Implementation of Low-dose CT Lung Cancer Screening: An ATS/CHEST Policy Statement (2015)
- Research Framework for Pulmonary Nodule Evaluation and Management: An ATS Research Statement (2015)
- Components Necessary for Lung Cancer Screening: An ATS/ACCP Policy Statement (2014)
- The Choosing Wisely Top 5 List in Adult Pulmonary Medicine: An Official ATS/ACCP Policy Statement (2014)
- The Role of the Pulmonologist in Lung Cancer: An Official ATS/ERS Statement (2013)
- IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma (2011)
- Noninfectious Lung Injury After Hematopoietic Stem Cell Transplantation Idiopathic Pneumonia Syndrome: An Official ATS Research Statement (2011)
- Insurance Status and Disparities in Lung Cancer Practices and Outcomes: An Official ATS Systematic Review (2010)
